Publications by authors named "T M Korman"

Background: Burkholderia cenocepacia complex is an important cause of hospital acquired infections. We describe the management of an outbreak in a neonatal intensive care unit (NICU) due to tap colonisation.

Methods: Microbiological testing of touch (n = 26) and non-touch taps (n = 28), sinks and drains, including genomic sequencing of selected isolates.

View Article and Find Full Text PDF

Background: Sepsis is a significant cause of neonatal mortality. Both clinical and laboratory markers are often non- specific, and a blood culture contaminant may confuse management of the infant. This study aims to use an existing, inexpensive test, the neutrophil-to-lymphocyte ratio (NLR), to predict culture positivity and thus optimise antibiotic management.

View Article and Find Full Text PDF

Background: International consensus definitions for invasive aspergillosis (IA) in research are rigorous, yet clinically significant cases are often excluded from clinical studies for not meeting proven/probable IA case definitions. To better understand reasons for the failure to meet criteria for proven/probable infection, we herein review 47 such cases for their clinical and microbiological characteristics and outcomes.

Methods: Data on 47 cases that did not meet consensus IA definitions but were deemed significant were derived from a retrospective, observational, multicenter survey of 382 presumed IA cases across Australasia, of which findings of 221 proven/probable infections were recently published.

View Article and Find Full Text PDF
Article Synopsis
  • Outpatient parenteral antimicrobial therapy (OPAT) can effectively treat fungal infections while reducing the treatment burden and costs, particularly by using the longer dosing intervals of rezafungin.
  • A study of 386 patients from 2012 to 2022 found that 11% were treated with echinocandins via OPAT, primarily for Candida infections, achieving a 73% treatment success rate.
  • Switching from daily to weekly echinocandin dosing could potentially cut treatment sessions by 52%, although the ongoing need for daily antibiotics limited some of these benefits.
View Article and Find Full Text PDF
Article Synopsis
  • Annual influenza epidemics significantly impact global health and economy, but their activity dropped during the COVID-19 pandemic, only to resurge in Australia in early 2022, coinciding with the Omicron variant wave.
  • * The current influenza vaccination program in Australia recommends yearly vaccinations for all individuals aged 6 months and older, with free vaccines provided for at-risk groups, but overall coverage, particularly among younger populations, remains low.
  • * To improve vaccination rates, strategies such as better monitoring, culturally appropriate resources, and addressing specific population needs are essential for enhancing the overall effectiveness of the immunization program.
View Article and Find Full Text PDF